2004 drug approval highlights: FDA update.

Gary Laustsen, Lynn Wimmett

Research output: Contribution to journalArticle

11 Citations (Scopus)
Original languageEnglish (US)
JournalThe Nurse practitioner
Volume30
Issue number2
StatePublished - 2005
Externally publishedYes

Fingerprint

Scopolamine Derivatives
Heptanoic Acids
Rifamycins
Ketolides
Glutamates
Cutaneous Administration
Memantine
Gastrointestinal Agents
Drug Approval
Cardiovascular Agents
Thiophenes
Amlodipine
Spironolactone
Postmenopausal Osteoporosis
Pyrroles
Bronchodilator Agents
Drug Combinations
Antidepressive Agents
Estradiol
Anti-Bacterial Agents

Cite this

2004 drug approval highlights : FDA update. / Laustsen, Gary; Wimmett, Lynn.

In: The Nurse practitioner, Vol. 30, No. 2, 2005.

Research output: Contribution to journalArticle

@article{13f37919c34945b4a08f4df8860a8c79,
title = "2004 drug approval highlights: FDA update.",
author = "Gary Laustsen and Lynn Wimmett",
year = "2005",
language = "English (US)",
volume = "30",
journal = "Nurse Practitioner",
issn = "0361-1817",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - 2004 drug approval highlights

T2 - FDA update.

AU - Laustsen, Gary

AU - Wimmett, Lynn

PY - 2005

Y1 - 2005

UR - http://www.scopus.com/inward/record.url?scp=18444389973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18444389973&partnerID=8YFLogxK

M3 - Article

C2 - 2005077431

AN - SCOPUS:18444389973

VL - 30

JO - Nurse Practitioner

JF - Nurse Practitioner

SN - 0361-1817

IS - 2

ER -